Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
Status:
Terminated
Trial end date:
2017-10-11
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies copper Cu 64-DOTA-B-Fab positron emission tomography
(PET)/computed tomography (CT) in imaging patients with ovarian and breast cancer. Cancer
antigen (CA)6 is an antigen (substance) found on the surface of several types of cancer cells
such as cancer of the ovary and breast. Diagnostic procedures, such as copper Cu
64-DOTA-B-Fab PET/CT, may help identify CA6 positive tumors and allow doctors to plan better
treatment.